Karyopharm Therapeutics Inc (KPTI)
1.085
+0.06
(+5.34%)
USD |
NASDAQ |
May 01, 16:00
1.085
0.00 (0.00%)
After-Hours: 17:34
Karyopharm Therapeutics Accounts Receivable (Quarterly): 26.96M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 26.96M |
September 30, 2023 | 37.92M |
June 30, 2023 | 32.28M |
March 31, 2023 | 35.20M |
December 31, 2022 | 47.09M |
September 30, 2022 | 27.45M |
June 30, 2022 | 23.48M |
March 31, 2022 | 24.99M |
December 31, 2021 | 22.50M |
September 30, 2021 | 18.75M |
June 30, 2021 | 17.89M |
Date | Value |
---|---|
March 31, 2021 | 17.84M |
December 31, 2020 | 12.88M |
September 30, 2020 | 11.06M |
June 30, 2020 | 9.581M |
March 31, 2020 | 9.281M |
December 31, 2019 | 7.862M |
September 30, 2019 | 7.928M |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
7.862M
Minimum
Dec 2019
47.09M
Maximum
Dec 2022
21.72M
Average
20.62M
Median
Accounts Receivable (Quarterly) Benchmarks
Geron Corp | -- |
Arbutus Biopharma Corp | 1.776M |
Verastem Inc | 0.00 |
Actinium Pharmaceuticals Inc | -- |
Chimerix Inc | 0.004M |